[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339110-105":59,"doc-detail-339110-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-novel-protein-biomarkers-from-the-blood-and-urine-for-the-early-diagnosis-of-bladder-cancer-via-proximity-extension-analysis","Identification of novel protein biomarkers from the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis","","Bladder cancer remains a highly prevalent and lethal urinary tract malignancy, motivating improved early detection. Using retrospectively collected serum and urine from patients with bladder cancer and healthy controls, the study measured 92 inflammation-related proteins via proximity extension analysis. Differential proteins were screened and the selected markers were validated with immunohistochemistry and single-cell sequencing. A LASSO-derived 14-protein signature distinguished cases from controls, outperforming FISH and showing stronger performance for early-stage, small, and low-grade disease.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-novel-protein-biomarkers-from-the-blood-and-urine-for-the-early-diagnosis-of-bladder-cancer-via-proximity-extension-analysis/339110/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-novel-protein-biomarkers-from-the-blood-and-urine-for-the-early-diagnosis-of-bladder-cancer-via-proximity-extension-analysis/339110.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What samples and platform were used to identify bladder cancer biomarkers?","Question",{"text":112,"@type":113},"The study used retrospectively collected serum and urine samples from bladder cancer patients and healthy controls, and quantified 92 inflammation-related proteins using proximity extension analysis (PEA).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which proteins were initially selected as potential biomarkers?",{"text":117,"@type":113},"Univariate analysis identified 40 serum proteins and 17 urine proteins with significant differences, and six proteins (AREG, RET, WFDC2, FGFBP1, ESM-1, and PVRL4) were selected for further evaluation.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the proposed diagnostic signature perform compared with FISH?",{"text":121,"@type":113},"A 14-protein signature built by LASSO regression distinguished bladder cancer from healthy controls with strong diagnostic metrics and showed better efficacy than FISH, especially for early-stage, small, and low-grade bladder cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339110,1790756935,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Kong et al. Journal of Translational Medicine (2024) 22:314  \n[https://doi.org/10.1186/s12967-024-04951-z](https://doi.org/10.1186/s12967-024-04951-z)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nIdentification of novel protein biomarkers  \nfrom the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis  \nTong Kong1, Yang Qu1, Taowa Zhao1, Zitong Niu1, Xiuyi Lv1, Yiting Wang1, Qiaojiao Ding1, Pengyao Wei1, Jun Fu3, Liang Wang4, Jing Gao3, Cheng Zhou2, Suying Wang5, Junhui Jiang2, Jianping Zheng1* , Kaizhe Wang1* and Kerong Wu2*  \nAbstract  \nBackground Bladder cancer (BC) is a very common urinary tract malignancy that has a high incidence and lethality. In this study, we identified BC biomarkers and described a new noninvasive detection method using serum and urine samples for the early detection of BC.  \nMethods Serum and urine samples were retrospectively collected from patients with BC (n = 99) and healthy controls (HC) (n = 50), and the expression levels of 92 inflammation-related proteins were examined via the proximity extension analysis (PEA) technique. Differential protein expression was then evaluated by univariate analysis (p \u003C 0. 05) . The expression of the selected potential marker was further verified in BC and adjacent tissues by immunohistochemistry (IHC) and single-cell sequencing. A model was constructed to differentiate BC from HC by LASSO regression and compared to the detection capability of FISH.  \nResults The univariate analysis revealed significant differences in the expression levels of 40 proteins in the serum (p \u003C 0. 05) and 17 proteins in the urine (p \u003C 0. 05) between BC patients and HC. Six proteins (AREG, RET, WFDC2, FGFBP1, ESM-1, and PVRL4) were selected as potential BC biomarkers, and their expression was evaluated at the protein and transcriptome levels by IHC and single-cell sequencing, respectively. A diagnostic model (a signature) consisting of 14 protein markers (11 in serum and three in urine) was also established using LASSO regression to distinguish between BC patients and HC (area under the curve = 0 . 91, PPV = 0 . 91, sensitivity = 0 . 87, and specificity = 0 . 82) . Our model showed better diagnostic efficacy than FISH, especially for early-stage, small, and low-grade BC.  \nConclusion Using the PEA method, we identified a panel of potential protein markers in the serum and urine of BC patients. These proteins are associated with the development of BC. A total of 14 of these proteins can be used to detect early-stage, small, low-grade BC. Thus, these markers are promising for clinical translation to improve the prognosis of BC patients.  \n*Correspondence:  \nJianping Zheng [zhengjianping@nimte.ac.cn](zhengjianping@nimte.ac.cn)[ ](zhengjianping@nimte.ac.cn)Kaizhe Wang [wangkaizhe@nimte.ac.cn](wangkaizhe@nimte.ac.cn)[ ](wangkaizhe@nimte.ac.cn)Kerong Wu [wkr1983@163.com](wkr1983@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commo","cbCaiaatHDhFJCNR","https://ap.wps.com/l/cbCaiaatHDhFJCNR","pdf",10820670,14,"English","# Background\n## Study rationale and clinical need\n# Methods\n## Sample collection and proximity extension analysis\n## Validation and model construction\n# Results\n## Differential proteins and biomarker panel\n## Diagnostic performance of the signature\n# Conclusion\n## Clinical translation potential for early detection","[{\"question\":\"What samples and platform were used to identify bladder cancer biomarkers?\",\"answer\":\"The study used retrospectively collected serum and urine samples from bladder cancer patients and healthy controls, and quantified 92 inflammation-related proteins using proximity extension analysis (PEA).\"},{\"question\":\"Which proteins were initially selected as potential biomarkers?\",\"answer\":\"Univariate analysis identified 40 serum proteins and 17 urine proteins with significant differences, and six proteins (AREG, RET, WFDC2, FGFBP1, ESM-1, and PVRL4) were selected for further evaluation.\"},{\"question\":\"How does the proposed diagnostic signature perform compared with FISH?\",\"answer\":\"A 14-protein signature built by LASSO regression distinguished bladder cancer from healthy controls with strong diagnostic metrics and showed better efficacy than FISH, especially for early-stage, small, and low-grade bladder cancer.\"}]","Identification of novel protein biomarkers from the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis | PDF",1790027931,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/edb858c8654d53301ce96db60d853937.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04a249b3065b41d47cf0eae6922d8eda.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1af731e2e35eca31a22d75a7cdb1359.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9ab7992a3c0cdb5874d74da7648f62f.webp",980,1301]